India Quotient was the first investor in ShareChat, Sugar Cosmetics, Lendingkart, Kuku FM, Vyapar, and several other startups. India Quotient, an early-stage investor, has raised $129 million in its ...

India Quotient, a Bengaluru-based early-stage venture capital firm, has made the final close of its fifth fund at $129 million (around Rs 1,132 crore), marking its largest fundraise to date. The new ...

HomeEssentials, a home and kitchen brand known for its modern, multi-use products, has raised $2.2 million in funding from early-stage venture capital firm India Quotient. The company plans to use the ...

The Philippines' mental health quotient (MHQ) has worsened in 2024 to 68.76 from 2023's recorded mental health quotient of 78.44, based on the Mental State of the World report by Sapien Labs, ...

Bengaluru: Venture capital firm India Quotient is looking to raise $130 million for its fifth fund, with nearly 80% of the commitments expected to come from global investors, its founding partner ...

For Java-based programs such as Maven, Jenkins, Gradle or Tomcat to run, they need to know that Java's JDK is installed. That's the purpose of the JAVA_HOME environment variable. It tells programs ...

Quotient Therapeutics emerged from stealth Nov. 21 with $50 million in funding from the life science investment firm Flagship Pioneering. Quotient’s platform hunts for new drug targets by using ...

The round also saw participation from Java Capital and 2am VC, along with angel investors - Tracxn cofounder Abhishek Goyal and GSF founder Rajesh Sawhney Founded in 2023 by Anshu Kandhari, Pankaj ...

Led by Arali Ventures, the funding round also saw participation from Java Capital, PeerCheque, DeVC by Matrix Partners, and Tracxn cofounder Abhishek Goyal Quash plans to utilise the funds to ...

Community driven content discussing all aspects of software development from DevOps to design patterns. The latest long-term support (LTS) release of the JDK is Java 21, which was released in ...

Quotient Sciences, a CDMO, reports that it has installed Centillion’s™ Biofoundry-in-a-Box (BiaB™), a multi-product GMP platform technology for end-to-end RNA manufacture. BiaB is a modular, ...